Carroll Jill

CIK 00015985424 companiesREDWOOD CITY, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001598542

Recent Transactions

35 trades

Conversion
Avalyn Pharma Inc.$AVLN
Common Stock
2026-05-01+1,419,298→ 1,419,298 total
Conversion
Avalyn Pharma Inc.$AVLN
Common Stock
2026-05-01+489,486→ 1,908,784 total
Purchase
Avalyn Pharma Inc.$AVLN
Common Stock
2026-05-01$18.00/sh+277,778→ 2,186,562 total
Conversion
Avalyn Pharma Inc.$AVLN
Series C-1 Convertible Preferred Stock
2026-05-01−27,309,719→ 0 total
Conversion
Avalyn Pharma Inc.$AVLN
Series D Convertible Preferred Stock
2026-05-01−9,418,561→ 0 total
Disposition from Tender
Arcellx, Inc.$ACLX
Common Stock
2026-04-28−1,479,148→ 0 total
Disposition to Issuer
Arcellx, Inc.$ACLX
Stock Option (right to buy)
2026-04-28−11,459→ 0 total
Disposition to Issuer
Arcellx, Inc.$ACLX
Stock Option (right to buy)
2026-04-28−8,011→ 0 total
Disposition to Issuer
Arcellx, Inc.$ACLX
Stock Option (right to buy)
2026-04-28−9,174→ 0 total
Award
Arcellx, Inc.$ACLX
Stock Option (right to buy)
2025-05-29+9,174→ 9,174 total
Award
Arcellx, Inc.$ACLX
Stock Option (right to buy)
2024-05-28+8,011→ 8,011 total
Sale
Arcellx, Inc.$ACLX
Common Stock
2024-03-21$70.55/sh−504,263→ 1,479,148 total
Sale
Arcellx, Inc.$ACLX
Common Stock
2023-12-14$49.13/sh−504,263→ 1,983,411 total
Award
Arcellx, Inc.$ACLX
Stock Option (right to buy)
2023-06-14+11,459→ 11,459 total
Sale
Arcellx, Inc.$ACLX
Common Stock
2023-06-01$44.35/sh−25,556→ 2,487,674 total
Sale
Arcellx, Inc.$ACLX
Common Stock
2023-05-31$41.50/sh−315,164→ 2,513,230 total
Sale
Arcellx, Inc.$ACLX
Common Stock
2023-05-11$45.00/sh−631,932→ 2,834,879 total
Sale
Arcellx, Inc.$ACLX
Common Stock
2023-05-11$46.15/sh−6,485→ 2,828,394 total
Purchase
Arcellx, Inc.$ACLX
Common Stock
2022-02-08$15.00/sh+66,667→ 3,466,811 total
Conversion
Arcellx, Inc.$ACLX
Series B-1 Preferred Stock
2022-02-08−666,651→ 0 total
Conversion
Arcellx, Inc.$ACLX
Common Stock
2022-02-08+3,400,144→ 3,400,144 total
Conversion
Arcellx, Inc.$ACLX
Series A Preferred Stock
2022-02-08−1,550,309→ 0 total
Conversion
Arcellx, Inc.$ACLX
Series C Preferred Stock
2022-02-08−433,196→ 0 total
Conversion
Arcellx, Inc.$ACLX
Common Stock
2022-02-08+433,196→ 433,196 total
Purchase
Arcellx, Inc.$ACLX
Common Stock
2022-02-08$15.00/sh+1,600,000→ 2,033,196 total
Conversion
Arcellx, Inc.$ACLX
Series B-2 Preferred Stock
2022-02-08−533,389→ 0 total
Conversion
Arcellx, Inc.$ACLX
Series C Preferred Stock
2022-02-08−649,795→ 0 total
Disposition from Tender
Pandion Therapeutics, Inc.
Common Stock
2021-04-01$60.00/sh−5,674,221→ 0 total
Disposition to Issuer
Pandion Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2021-04-01−13,997→ 0 total
Conversion
Pandion Therapeutics, Inc.
Series B Preferred Stock
2020-07-21−1,776,980→ 0 total
Purchase
Pandion Therapeutics, Inc.
Common Stock
2020-07-21$18.00/sh+361,111→ 2,248,304 total
Conversion
Pandion Therapeutics, Inc.
Common Stock
2020-07-21+348,469→ 1,887,193 total
Conversion
Pandion Therapeutics, Inc.
Series A Preferred Stock
2020-07-21−7,846,554→ 0 total
Conversion
Pandion Therapeutics, Inc.
Common Stock
2020-07-21+1,538,724→ 1,538,724 total
Award
Pandion Therapeutics, Inc.
Stock Option (right to buy)
2020-07-17+13,997→ 13,997 total

Companies

Recent Filings

Address

929 MAIN STREET SUITE 200

REDWOOD CITY, CA, 94063

View on SEC.gov